Anixa Biosciences Inc. (NASDAQ: ANIX)
$3.1100
+0.0200 ( +0.65% ) 101.7K
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Market Data
Open
$3.1100
Previous close
$3.0900
Volume
101.7K
Market cap
$99.22M
Day range
$3.0710 - $3.2790
52 week range
$2.1450 - $5.1300
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
4 | Insider transactions | 1 | Jan 16, 2024 |
8-k | 8K-related | 16 | Dec 07, 2023 |
4 | Insider transactions | 1 | Nov 02, 2023 |
4 | Insider transactions | 1 | Oct 11, 2023 |
10-q | Quarterly Reports | 57 | Sep 06, 2023 |